Security key
14817C107
FILANA THERAPEUTICS, INC. - Common Stock (FLNA)
CUSIP: 14817C107
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 285
- Total 13F value
- $340
- Share change
- 0
- SEC-reported price per share
- $1.20
- Number of holders
- 2
- Shares outstanding
- 48,331,225
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
3
FLNA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
FILANA THERAPEUTICS, INC. SEC filings
FILANA THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14817C107
Recent filing periods:
Ownership snapshot
Top reported holders of FLNA - FILANA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nachtrab Matthew
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 4.7%
13D/G row: Nachtrab Matthew
Showing 1-6 of 15 holder rows.
Quick read
Nachtrab Matthew leads the comparable SEC ownership view at 4.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nachtrab Matthew's linked filing trail.
Comparable ownership
Top 5
Nachtrab Matthew
4.7%
VANGUARD GROUP INC
4.5%
BlackRock, Inc.
3.2%
MARSHALL WACE, LLP
4.2%
TWO SIGMA INVESTMENTS, LP
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nachtrab Matthew |
13D/G
|
4.7%
|
$3,560,189
2,267,636 shares
|
$0 | 16 Aug 2024 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
4.5%
|
$3,927,830
2,170,072 shares
|
$0 | 30 Jun 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
3.2%
|
$2,797,129
1,545,375 shares
|
$0 | 30 Jun 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
4.2%
|
$3,401,201
2,012,543 shares
|
— | 31 Mar 2026 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
4.1%
|
$3,361,096
1,988,814 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
4%
|
$3,263,294
1,930,943 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
285
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
99
Q2 2026 holders
2
Holder diff
-97
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend